ABALX - American Funds Ame... Stock Analysis | Stock Taper
Logo
American Funds American Balanced A

ABALX

American Funds American Balanced A NASDAQ
$40.62 0.22% (+0.09)

Market Cap $288.44 B
52w High $41.11
52w Low $36.31
Dividend Yield 7.09%
Frequency Quarterly
P/E 26.41
Volume 0
Outstanding Shares 7.12B

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2023 $187.61M $1.74M $20.57M 10.96% $1.17 $27.45M
Q3-2023 $221.08M $2.87M $26.08M 11.79% $1.49 $36.14M
Q2-2023 $211.98M $5.57M $9.05M 4.27% $0.52 $14.23M
Q1-2023 $212.71M $9.14M $5.24M 2.46% $0.3 $8.82M
Q4-2022 $200.17M $2.6M $8.16M 4.08% $0.47 $12.65M

What's going well?

The company remains profitable and has no debt burden. Operating expenses were trimmed, and earnings are clean without one-time charges.

What's concerning?

Revenue and profits dropped sharply, and margins are getting squeezed. The business appears low-margin and vulnerable to further declines if sales keep falling.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2023 $378.66M $664.8M $77.2M $513.92M
Q3-2023 $332M $627.56M $62.02M $492.99M
Q2-2023 $284.38M $592.94M $59.39M $466.56M
Q1-2023 $265.81M $566.54M $49.14M $453.64M
Q4-2022 $280.94M $579.58M $68.58M $447.98M

What's financially strong about this company?

The company has a huge cash pile, very little debt, and most assets are real and easy to value. Liquidity is excellent, and equity keeps growing, showing ongoing profitability.

What are the financial risks or weaknesses?

There are few risks—one minor concern is that payables are rising, which could mean they're delaying payments. Also, the drop in investments could mean less income from that source.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2023 $20.57M $60.78M $91.67M $-3.61M $148.84M $45.47M
Q3-2023 $26.08M $58.55M $-88.17M $0 $-29.62M $44.37M
Q2-2023 $9.05M $19.26M $3.87M $0 $23.13M $15.29M
Q1-2023 $5.24M $-10.63M $21.04M $-716K $9.7M $-14.83M
Q4-2022 $8.16M $801K $-64.48M $-2.27M $-65.95M $-7.59M

What's strong about this company's cash flow?

ABALX generates more cash than it reports as profit, with $60.8 million in operating cash flow and $45.5 million in free cash flow this quarter. Cash is growing fast, and the company doesn't rely on outside funding.

What are the cash flow concerns?

Net income dropped this quarter, and the big cash increase was helped by one-time investing activity. Working capital changes may not repeat, and no cash is being returned to shareholders.

5-Year Trend Analysis

A comprehensive look at American Funds American Balanced A's financial evolution and strategic trajectory over the past five years.

+ Strengths

ABALX combines solid current profitability, strong conversion of earnings into cash, and a very conservative balance sheet with ample liquidity and minimal debt. It sits within a highly reputable, research‑driven asset manager that uses a multi‑manager system, deep analyst resources, and long‑term discipline. Its long history, strong brand, and significant scale in the balanced‑fund space further support its position.

! Risks

Key risks include the lack of multi‑year financial detail in this data set, making it difficult to assess how resilient profitability and cash flow are across market cycles. As an actively managed balanced fund, it faces intense competition and fee pressure from index products and alternative allocation solutions. The absence of explicit R&D spending on the statements, reliance on market performance of underlying holdings, potential leadership changes, and evolving regulation all represent ongoing uncertainties.

Outlook

Based on the information available, ABALX appears financially sound and operationally disciplined, with a well‑established competitive position supported by a strong parent organization and continuous process‑focused innovation. Its future will depend on how effectively it maintains investment discipline, adapts to industry fee and regulatory pressures, and leverages its research and technology investments. Outcomes for investors will ultimately be driven by market conditions and execution, rather than by balance‑sheet strength alone.